10-K: Mannatech Reports Improved Profitability Despite Sales Dip in 2024
Annual Results
Mannatech's 2024 10-K filing reveals a net income turnaround despite a decrease in net sales, driven by cost control and foreign exchange gains.
Summary
- Mannatech's 2024 net sales decreased by 10.7% to $117.9 million compared to $132.0 million in 2023.
- The company reported operating income of $1.4 million in 2024, a significant improvement from the $1.0 million operating loss in 2023.
- Net income for 2024 was $2.5 million, or $1.32 per diluted share, compared to a net loss of $2.2 million, or $1.20 per diluted share, in 2023.
- The Americas region experienced a 7.2% decrease in sales, while Asia/Pacific sales decreased by 13.1%.
- EMEA sales decreased by 6.1% in 2024.
- The company's gross profit margin decreased slightly from 78.0% in 2023 to 77.6% in 2024.
- Mannatech's cash and cash equivalents increased to $11.4 million at the end of 2024 from $7.7 million at the end of 2023.
- The company entered into unsecured loan agreements with three related parties for an aggregate principal amount of $3.6 million to provide funds for general working capital needs.
Sentiment
Score: 6
Explanation: The document presents a mixed picture. While profitability improved, sales declined, and the company relies on loans from related parties. The outlook is cautiously optimistic.
Positives
- The company achieved a net income of $2.5 million in 2024, a turnaround from a net loss of $2.2 million in the previous year.
- Operating income improved significantly, reaching $1.4 million compared to a $1.0 million loss in 2023.
- Cash and cash equivalents increased to $11.4 million at the end of 2024.
- Foreign currency gains provided a boost to net income.
Negatives
- Net sales decreased by 10.7% to $117.9 million, with declines in all three operating regions.
- Gross profit margin decreased slightly from 78.0% in 2023 to 77.6% in 2024.
Risks
- The company's future success depends on attracting and retaining independent associates.
- The loss of key management personnel could adversely affect the business.
- Failure to protect proprietary rights could harm the company's competitive position.
- The company is subject to extensive governmental regulations, and changes in these regulations could adversely affect the business.
- The company is exposed to currency exchange rate fluctuations, which could reduce overall profits.
- The company relies on existing cash balances and cash flow from operations to fund its business and meet its contractual obligations.
- The company has outstanding debt with its directors, which could adversely affect its cash flow and its ability to pursue desirable business opportunities.
Future Outlook
The company believes its existing liquidity and cash flows from operations are adequate to fund its normal expected future business operations for the next twelve months.
Management Comments
- Management has established a 2024 business reorganization plan focusing on revenue growth, margin improvement and cost control and reduction.
Industry Context
The nutritional supplement industry is fast paced, highly fragmented, and intensely competitive.
Comparison to Industry Standards
- The document mentions several competitors including AdvoCare International, GNC Holdings, Inc., Herbalife Nutrition Ltd., Natures Sunshine Products, Inc., NOW Foods, Nu Skin Enterprises, Inc., Reliv International, Inc., Solgar Vitamin and Herb Company, Inc., Swanson Health Products, Usana Health Sciences, Inc., and Vitamin Shoppe Industries, Inc.
- The document also mentions Amway Corporation, Forever Living Products, Inc., Mary Kay, Inc., and Shaklee Worldwide as competitors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Alfredo (Al) Bala | Landen Fredrick | 2024-04-01 | Retirement |
Related Party Transactions
- The company entered into unsecured loan agreements with three related parties, who are members of the company's Board of Directors, and who are current stockholders of the company, in an aggregate principal amount of $3.6 million.
- The company made cash donations of $0.4 million and $0.5 million to the M5M Foundation for the years ended December 31, 2024 and 2023, respectively, where several of the company's directors and officers and their family members serve on the board.
Stakeholder Impact
- Shareholders may be concerned about the decline in net sales but encouraged by the improvement in profitability.
- Independent associates may be affected by changes to the compensation plan.
- Employees may be affected by the company's reorganization plan and cost control measures.
Next Steps
- The company will focus on revenue growth, margin improvement, and cost control as part of its 2024 business reorganization plan.
Key Dates
| Date | Description |
|---|---|
| 1993-11-04 | Mannatech, Incorporated was incorporated in the state of Texas. |
| 1997-05-09 | Mannatech adopted a Defined Contribution 401(k) and Profit Sharing Plan for its United States and Canada employees. |
| 1998-05-19 | Mannatech amended its Amended and Restated Articles of Incorporation to reduce the number of authorized shares of common stock and authorized shares of preferred stock. |
| 1999-02-12 | Mannatech completed its initial public offering. |
| 2004-06-30 | The Company's Board of Directors authorized the Company to repurchase, in the open market, the lesser of (i) 131,756 shares of its common stock and (ii) $1.3 million of its shares. |
| 2006-08-28 | The Company's Board of Directors authorized a second program permitting the Company to purchase, in the open market, up to $20 million of its outstanding shares. |
| 2017-04-17 | The 2017 Stock Incentive Plan was adopted by the Company's Board of Directors. |
| 2017-06-08 | The 2017 Stock Incentive Plan was approved by the Company's shareholders. |
| 2019-02 | The 2017 Stock Incentive Plan was amended by the Board. |
| 2019-06-11 | The amended 2017 Stock Incentive Plan was approved by the Company's shareholders. |
| 2024-04-01 | Alfredo (Al) Bala retired as the Company's Chief Executive Officer and was engaged as an advisor to the Company. |
| 2024-04-17 | The 2017 Stock Incentive Plan expires. |
| 2024-04-23 | The Company issued unsecured notes payable to Jade Capital, J. Stanley Fredrick, and Kevin Robbins. |
| 2024-07 | The Company ceased operating its tiered affiliate program in the United States which conducted business under the brand name, Trulu. |
| 2024-09-30 | The Company's common stock began trading on The Nasdaq Capital Market. |
| 2025-02-01 | The current portion of notes payable related to insurance financing arrangements reached maturity and was paid in full. |
| 2025-03-18 | As of this date, there were 1,031 shareholders of record. |
Keywords
Mannatech, financial results, net sales, net income, operating income, nutritional supplements, direct selling, 10-K, financial report
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.